French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis - 2021 update. Full-length version
Copyright © 2022. Published by Elsevier Masson SAS..
BACKGROUND: Since the latest 2017 French guidelines, knowledge about idiopathic pulmonary fibrosis has evolved considerably.
METHODS: Practical guidelines were drafted on the initiative of the Coordinating Reference Center for Rare Pulmonary Diseases, led by the French Language Pulmonology Society (SPLF), by a coordinating group, a writing group, and a review group, with the involvement of the entire OrphaLung network, pulmonologists practicing in various settings, radiologists, pathologists, a general practitioner, a health manager, and a patient association. The method followed the "Clinical Practice Guidelines" process of the French National Authority for Health (HAS), including an online vote using a Likert scale.
RESULTS: After a literature review, 54 guidelines were formulated, improved, and then validated by the working groups. These guidelines addressed multiple aspects of the disease: epidemiology, diagnostic procedures, quality criteria and interpretation of chest CT scans, lung biopsy indication and procedures, etiological workup, methods and indications for family screening and genetic testing, assessment of the functional impairment and prognosis, indication and use of antifibrotic agents, lung transplantation, management of symptoms, comorbidities and complications, treatment of chronic respiratory failure, diagnosis and management of acute exacerbations of fibrosis.
CONCLUSION: These evidence-based guidelines are intended to guide the diagnosis and practical management of idiopathic pulmonary fibrosis.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:83 |
|---|---|
| Enthalten in: |
Respiratory medicine and research - 83(2023) vom: 20. Juni, Seite 100948 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
Biopsy |
|---|
| Anmerkungen: |
Date Completed 09.06.2023 Date Revised 09.06.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.resmer.2022.100948 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM351417540 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM351417540 | ||
| 003 | DE-627 | ||
| 005 | 20231226051321.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.resmer.2022.100948 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1171.xml |
| 035 | |a (DE-627)NLM351417540 | ||
| 035 | |a (NLM)36630775 | ||
| 035 | |a (PII)S2590-0412(22)00064-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Cottin, Vincent |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis - 2021 update. Full-length version |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 09.06.2023 | ||
| 500 | |a Date Revised 09.06.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2022. Published by Elsevier Masson SAS. | ||
| 520 | |a BACKGROUND: Since the latest 2017 French guidelines, knowledge about idiopathic pulmonary fibrosis has evolved considerably | ||
| 520 | |a METHODS: Practical guidelines were drafted on the initiative of the Coordinating Reference Center for Rare Pulmonary Diseases, led by the French Language Pulmonology Society (SPLF), by a coordinating group, a writing group, and a review group, with the involvement of the entire OrphaLung network, pulmonologists practicing in various settings, radiologists, pathologists, a general practitioner, a health manager, and a patient association. The method followed the "Clinical Practice Guidelines" process of the French National Authority for Health (HAS), including an online vote using a Likert scale | ||
| 520 | |a RESULTS: After a literature review, 54 guidelines were formulated, improved, and then validated by the working groups. These guidelines addressed multiple aspects of the disease: epidemiology, diagnostic procedures, quality criteria and interpretation of chest CT scans, lung biopsy indication and procedures, etiological workup, methods and indications for family screening and genetic testing, assessment of the functional impairment and prognosis, indication and use of antifibrotic agents, lung transplantation, management of symptoms, comorbidities and complications, treatment of chronic respiratory failure, diagnosis and management of acute exacerbations of fibrosis | ||
| 520 | |a CONCLUSION: These evidence-based guidelines are intended to guide the diagnosis and practical management of idiopathic pulmonary fibrosis | ||
| 650 | 4 | |a Review | |
| 650 | 4 | |a Practice Guideline | |
| 650 | 4 | |a Biopsy | |
| 650 | 4 | |a Interstitial lung disease | |
| 650 | 4 | |a Pulmonary fibrosis | |
| 650 | 4 | |a Usual interstitial pneumonia | |
| 700 | 1 | |a Bonniaud, Philippe |e verfasserin |4 aut | |
| 700 | 1 | |a Cadranel, Jacques |e verfasserin |4 aut | |
| 700 | 1 | |a Crestani, Bruno |e verfasserin |4 aut | |
| 700 | 1 | |a Jouneau, Stéphane |e verfasserin |4 aut | |
| 700 | 1 | |a Marchand-Adam, Sylvain |e verfasserin |4 aut | |
| 700 | 1 | |a Nunes, Hilario |e verfasserin |4 aut | |
| 700 | 1 | |a Wémeau-Stervinou, Lidwine |e verfasserin |4 aut | |
| 700 | 1 | |a Bergot, Emmanuel |e verfasserin |4 aut | |
| 700 | 1 | |a Blanchard, Elodie |e verfasserin |4 aut | |
| 700 | 1 | |a Borie, Raphaël |e verfasserin |4 aut | |
| 700 | 1 | |a Bourdin, Arnaud |e verfasserin |4 aut | |
| 700 | 1 | |a Chenivesse, Cécile |e verfasserin |4 aut | |
| 700 | 1 | |a Clément, Annick |e verfasserin |4 aut | |
| 700 | 1 | |a Gomez, Emmanuel |e verfasserin |4 aut | |
| 700 | 1 | |a Gondouin, Anne |e verfasserin |4 aut | |
| 700 | 1 | |a Hirschi, Sandrine |e verfasserin |4 aut | |
| 700 | 1 | |a Lebargy, François |e verfasserin |4 aut | |
| 700 | 1 | |a Marquette, Charles-Hugo |e verfasserin |4 aut | |
| 700 | 1 | |a Montani, David |e verfasserin |4 aut | |
| 700 | 1 | |a Prévot, Grégoire |e verfasserin |4 aut | |
| 700 | 1 | |a Quetant, Sébastien |e verfasserin |4 aut | |
| 700 | 1 | |a Reynaud-Gaubert, Martine |e verfasserin |4 aut | |
| 700 | 1 | |a Salaun, Mathieu |e verfasserin |4 aut | |
| 700 | 1 | |a Sanchez, Olivier |e verfasserin |4 aut | |
| 700 | 1 | |a Trumbic, Bruno |e verfasserin |4 aut | |
| 700 | 1 | |a Berkani, Karim |e verfasserin |4 aut | |
| 700 | 1 | |a Brillet, Pierre-Yves |e verfasserin |4 aut | |
| 700 | 1 | |a Campana, Marion |e verfasserin |4 aut | |
| 700 | 1 | |a Chalabreysse, Lara |e verfasserin |4 aut | |
| 700 | 1 | |a Chatté, Gérard |e verfasserin |4 aut | |
| 700 | 1 | |a Debieuvre, Didier |e verfasserin |4 aut | |
| 700 | 1 | |a Ferretti, Gilbert |e verfasserin |4 aut | |
| 700 | 1 | |a Fourrier, Jean-Michel |e verfasserin |4 aut | |
| 700 | 1 | |a Just, Nicolas |e verfasserin |4 aut | |
| 700 | 1 | |a Kambouchner, Marianne |e verfasserin |4 aut | |
| 700 | 1 | |a Legrand, Bertrand |e verfasserin |4 aut | |
| 700 | 1 | |a Le Guillou, Frédéric |e verfasserin |4 aut | |
| 700 | 1 | |a Lhuillier, Jean-Pierre |e verfasserin |4 aut | |
| 700 | 1 | |a Mehdaoui, Anas |e verfasserin |4 aut | |
| 700 | 1 | |a Naccache, Jean-Marc |e verfasserin |4 aut | |
| 700 | 1 | |a Paganon, Catherine |e verfasserin |4 aut | |
| 700 | 1 | |a Rémy-Jardin, Martine |e verfasserin |4 aut | |
| 700 | 1 | |a Si-Mohamed, Salim |e verfasserin |4 aut | |
| 700 | 1 | |a Terrioux, Philippe |e verfasserin |4 aut | |
| 700 | 0 | |a OrphaLung network |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Respiratory medicine and research |d 2019 |g 83(2023) vom: 20. Juni, Seite 100948 |w (DE-627)NLM298429772 |x 2590-0412 |7 nnns |
| 773 | 1 | 8 | |g volume:83 |g year:2023 |g day:20 |g month:06 |g pages:100948 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.resmer.2022.100948 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 83 |j 2023 |b 20 |c 06 |h 100948 | ||